Despite the increasing numbers of infections, Covid vaccines are still effective, particularly if people are fully vaccinated, says Dr Paul Griffin, Director of Infectious Diseases at the Mater in Queensland.
With long COVID becoming recognised as a significant consequence of COVID infection, it is evident we will need to stay ahead of prevention and treatment of the new variants of this virus
In this Product Explainer, Paediatrician and Paediatric Immunologist A/Prof Peter Richmond explains which patients are most at risk for meningococcal B, the risk reduction benefits of meningococcal B vaccination and why it is important to have conversations with parents in which the risk/benefits of vaccination are clearly explained (5 mins).
Overseas travel and COVID - booster before travelling? What’s the evidence? The more transmissible OMICRON subvariant... is there any cause for concern here?
Key features of pertussis as it appears in adults, when to suspect it, and how to diagnose and treat it- the opportunities that exist to reduce the morbidity and mortality from whooping cough by targeting older adults.
In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).
In this Product Explainer, A/Prof John Litt AM, Public Health Physician explains the differences between the “traditional” egg-based influenza vaccines and the potential advantages of the first cell culture based influenza vaccine available in Australia (5 mins).